ArticleCellular and molecular life sciences : CMLS2025

SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2.

Xiang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.